Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High levels of fibrotic tumor components are associated with recurrence and intratumoral immune status in advanced colorectal cancer patients.
Dorjkhorloo G, Shiraishi T, Erkhem-Ochir B, Sohda M, Okami H, Yamaguchi A, Shioi I, Komine C, Nakazawa N, Shibasaki Y, Okada T, Osone K, Sano A, Sakai M, Ogawa H, Katayama A, Oyama T, Yokobori T, Shirabe K, Saeki H. Dorjkhorloo G, et al. Among authors: ogawa h. Sci Rep. 2024 Dec 28;14(1):30735. doi: 10.1038/s41598-024-80489-w. Sci Rep. 2024. PMID: 39730445 Free PMC article.
Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy.
Shibasaki Y, Yokobori T, Sohda M, Shioi I, Ozawa N, Komine C, Suga K, Nakazawa N, Osone K, Shiraishi T, Okada T, Sano A, Sakai M, Ogawa H, Kaira K, Shirabe K, Saeki H. Shibasaki Y, et al. Among authors: ogawa h. Int J Mol Sci. 2023 Jan 30;24(3):2604. doi: 10.3390/ijms24032604. Int J Mol Sci. 2023. PMID: 36768934 Free PMC article.
Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer.
Shioi I, Ogawa H, Naito R, Endo M, Hosoi N, Tateno K, Uchida S, Yamaguchi A, Watanabe T, Nakazawa N, Shibasaki Y, Komine C, Shiraishi T, Osone K, Okada T, Sano A, Sakai M, Sohda M, Shirabe K, Saeki H. Shioi I, et al. Among authors: ogawa h. Anticancer Res. 2024 Jul;44(7):3013-3023. doi: 10.21873/anticanres.17114. Anticancer Res. 2024. PMID: 38925838
Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer.
Komine C, Sohda M, Yokobori T, Shioi I, Ozawa N, Shibasaki Y, Nakazawa N, Osone K, Shiraishi T, Okada T, Sano A, Sakai M, Ogawa H, Kaira K, Shirabe K, Saeki H. Komine C, et al. Among authors: ogawa h. Ann Surg Oncol. 2024 Sep 28. doi: 10.1245/s10434-024-16195-8. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39341920
Albumin-derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study.
Nakazawa N, Sohda M, Tateno K, Watanabe T, Kimura A, Kogure N, Hosaka H, Naganuma A, Sekiguchi M, Saito K, Ogata K, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: ogawa h. In Vivo. 2023 Mar-Apr;37(2):818-824. doi: 10.21873/invivo.13147. In Vivo. 2023. PMID: 36881071 Free PMC article.
5,390 results